Realtime Foreign Exchange › Euro/US Dollar (FOREX:EURUSD)
1.101925 -0.005480 (-0.49%)
2015-03-05 15:11:33, 0 min delay
| Last Price | 1.101925 |
|---|---|
| Previous Close | 1.107405 |
| Low | 1.098780 |
| Ask | 1.102050 |
| Open | 1.107405 |
|---|---|
| High | 1.110200 |
| Bid | 1.101800 |
| Time | 2015-03-05 15:11:33 |
Free Instant Analysis: Let our Trade Triangle technology, brought to you courtesy of our premium service MarketClub, instantly analyze any stock, futures or forex market for you. It’s free, It’s informative, It’s on the money. View our complimentary trend analysis for Euro/US Dollar (EURUSD) now.
Trader's Blog
How to Position Your Portfolio for the Coming Gold Upturn
3 hours ago
Solid Trading Tips For 2015
7 hours ago
Here's What Stock Market Bulls Might Be Overlooking
23 hours ago
Today's Financial News
Royals pitcher Jeremy Guthrie helping to produce documentary on sneaker-collecting subculture
3 hours ago
SURPRISE, Ariz. (AP) — Jeremy Guthrie strode to the table with a television camera trained on him, settling down behind a pair of microphones. His voice clear and his words concise, Guthrie announced in a mock news conference that he was hanging up his cleats. From the business of shoe collecting.
Yale students protest work requirement for those receiving financial aid
3 hours ago
NEW HAVEN, Conn. (AP) — A requirement that Yale undergraduates on financial aid pay up to $6,400 annually toward their education is coming under protest from students who argue it creates a divide along class lines and keeps them from participating more in campus life. The Ivy League university with a $23.9 billion endowment has some of the nation's most generous aid policies, including a promise that students can graduate without any loans, but some students say they have been advised to borrow money when they had trouble meeting the financial obligation.
FDA says maker of endoscope linked to 'superbug' outbreak in LA did not seek federal approval
3 hours ago
WASHINGTON (AP) — The manufacturer of a medical instrument at the center of a recent "superbug" outbreak in Los Angeles did not receive federal clearance to sell the device, according to officials from the Food and Drug Administration. Despite the lack of clearance, the FDA said doctors should continue using the device because it's not clear that federal review would have prevented the recent infections reported in patients.
AbbVie to buy leukemia drugmaker Pharmacyclics for $21 billion in its first deal since Shire
3 hours ago
AbbVie will spend about $21 billion to buy fellow drugmaker Pharmacyclics in a bid to add another major revenue producer to a product portfolio that already includes the world's top-selling drug, the anti-inflammatory Humira. Imbruvica is approved in more than 40 countries and treats three different types of blood cancers including chronic lymphocytic leukemia, which is the most common leukemia in adults. The once-a-day capsule works by blocking a protein that allows the cancer to multiply and spread.
